Home › Funds › Freestone Grove Partners LP › ELV

Freestone Grove Partners LP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

Freestone Grove Partners LP reported holding 186,427 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$72.1M, representing 0.46% of its reported portfolio and ranking #49 among its reported holdings. Freestone Grove Partners LP has disclosed ELV holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)186.43K sh
Reported value held$72.10M
Portfolio Weight0.46%
First reportedQ1 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Freestone Grove Partners LP's ELV position evolved

Freestone Grove Partners LP first disclosed a stake in ELV in Q1 2025 at 167,256 shares (US$72.7M). The position peaked in Q4 2025 at 283,107 shares, worth US$99.2M. Across 4 filings, Freestone Grove Partners LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 186,427 shares valued at US$72.1M — a reduction of -20,796 shares quarter over quarter.. Notable position changes include a 27% trim in Q1 2026 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 167.26K $72.75M New
Q4 2025 283.11K $99.24M New
Q1 2026 207.22K $60.66M Reduce
Q2 2026 186.43K $72.10M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has Freestone Grove Partners LP held ELV?

Freestone Grove Partners LP has disclosed ELV holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

What is Freestone Grove Partners LP's current position in ELV?

As of Q2 2026, Freestone Grove Partners LP holds 186.43K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $72.10M, representing 0.46% of its reported portfolio and ranking #49.

Has Freestone Grove Partners LP been buying or selling ELV?

In the latest 13F filing (Q2 2026), Freestone Grove Partners LP reduced its position in ELV. The position peaked in Q4 2025 at 283.11K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.